Prion diseases: immunotargets and therapy

References

• WilliamsESChronic wasting diseaseVet Pathol200542553054916145200
   PubMed Web of Science ®Google Scholar
• SigurdsonCJAguzziAChronic wasting diseaseBiochim Biophys Acta20071772661061817223321
   PubMed Web of Science ®Google Scholar
• Cdc.gov [homepage on the internet]AtlantaCenters for Disease Control and Prevention [updated 2015 Nov 10]. Available from: http://www.cdc.gov/Accessed November 15, 2015
   Google Scholar
• HillAFDesbruslaisMJoinerSThe same prion strain causes vCJD and BSENature199738966504484509333232
   PubMed Web of Science ®Google Scholar
• GajdusekDCKuru: an appraisal of five years of investigationEugen Q196291697413896277
   PubMed Web of Science ®Google Scholar
• PanegyresPKGohJGoldblattJCodon 200 mutation of the prion gene: genotype-phenotype correlationsJ Neurol2012259122579258422584955
   PubMed Web of Science ®Google Scholar
• ZerrIPocchiariMCollinsSAnalysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob diseaseNeurology200055681181510994001
   PubMed Web of Science ®Google Scholar
• WindlODempsterMEstibeiroJPGenetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP geneHum Genet19969832592648707291
   PubMed Web of Science ®Google Scholar
• GlatzelMOttPMLinderTHuman prion diseases: epidemiology and integrated risk assessmentLancet Neurol200321275776314636781
   PubMed Web of Science ®Google Scholar
• HsiaoKBakerHFCrowTJLinkage of a prion protein missense variant to Gerstmann-Sträussler syndromeNature198933862133423452564168
   PubMed Web of Science ®Google Scholar
• BeekesMPrions and prion diseasesFEBS J2007274357517288546
   PubMed Web of Science ®Google Scholar
• NitriniRRosembergSPassos-BuenoMRA familial spongiform encephalopathy associated with a novel prion protein gene mutationAnn Neurol19974221381469266722
   PubMed Web of Science ®Google Scholar
• FinckhUMüller-ThomsenTMannUHigh prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genesAm J Hum Genet200066111011710631141
   PubMed Web of Science ®Google Scholar
• KiachopoulosSBracherAWinklhoferKFTatzeltJPathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchorJ Biol Chem2005280109320932915591591
   PubMed Web of Science ®Google Scholar
• van der KampMWDaggettVPathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfoldingJ Mol Biol2010404473274820932979
   PubMed Web of Science ®Google Scholar
• KovacsGGPuopoloMLadoganaAEUROCJDGenetic prion disease: the EUROCJD experienceHum Genet2005118216617416187142
   PubMed Web of Science ®Google Scholar
• CollingeJPalmerMSDrydenAJGenetic predisposition to iatrogenic Creutzfeldt-Jakob diseaseLancet19913378755144114421675319
   PubMed Web of Science ®Google Scholar
• GambettiPKongQZouWParchiPChenSGSporadic and familial CJD: classification and clarificationBr Med Bull200366121323914522861
   PubMed Web of Science ®Google Scholar
• LasmezasCIDeslysJPRobainOTransmission of the BSE agent to mice in the absence of detectable abnormal prion proteinScience199727552984024058994041
   PubMed Web of Science ®Google Scholar
• CaugheyBKociskoDARaymondGJLansburyPTJrAggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant stateChem Biol19952128078178807814
   PubMed Web of Science ®Google Scholar
• AguzziACalellaAMPrions: protein aggregation and infectious diseasesPhysiol Rev20098941105115219789378
   PubMed Web of Science ®Google Scholar
• PanegyresPKArmariETherapies for human prion diseasesAm J Neurodegener Dis20132317618624093082
   PubMedGoogle Scholar
• GauczynskiSNiklesDEl-GogoSThe 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycansJ Infect Dis2006194570270916897671
   PubMed Web of Science ®Google Scholar
• LeuchtCVanaKRenner-MullerIKnock-down of the 37-kDa laminin receptor in mouse brain by transgenic expression of specific antisense LRP RNATransgenic Res2004131818515070079
   PubMed Web of Science ®Google Scholar
• Larramendy-GozaloCBarretADaudigeousEComparison of CR36, a new heparin mimetic, and pentosan polysulfate in the treatment of therapies for human prion diseasesAm J Neurodegener Dis20132317618624093082
   PubMedGoogle Scholar
• MacGregorIVDawesJPatonLPepperDSProwseCVSmithMMetabolism of sodium pentosan polysulphate in man. Catabolism of iodinated derivativesThromb Haemost19845133213256208629
   PubMed Web of Science ®Google Scholar
• FarquharCDickinsonABruceMProphylactic potential of pentosan polysulphate in transmissible spongiform encephalopathiesLancet1999353914711710023899
   PubMed Web of Science ®Google Scholar
• ParryABakerIStaceyRWimalaratnaSLong term survival in a patient with variant Creutzfeldt-Jakob disease treated with intra-ventricular pentosan polysulphateJ Neurol Neurosurg Psychiatry200778773373417314188
   PubMed Web of Science ®Google Scholar
• BoneLBeltonLWalkerASDarbyshireJIntraventricular pentosan polysulphate in human prion diseases: an observational study in the UKEur J Neurol200815545846418355301
   PubMed Web of Science ®Google Scholar
• Doh-uraKIshikawaKMurakami-KuboITreatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal modelsJ Virol200478104999500615113880
   PubMed Web of Science ®Google Scholar
• Murakami-KuboIDoh-UraKIshikawaKQuinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathiesJ Virol20047831281128814722283
   PubMed Web of Science ®Google Scholar
• HaïkSBrandelJPSalomonDCompassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effectsNeurology200463122413241515623716
   PubMed Web of Science ®Google Scholar
• CollingeJGorhamMHudsonFSafety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trialLancet Neurol20098433434419278902
   PubMed Web of Science ®Google Scholar
• PocchiariMSchmittingerSMasulloCAmphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamstersJ Gen Virol19876812192232433387
   PubMed Web of Science ®Google Scholar
• DemaimayRAdjouKTBeringueVLate treatment with polyene antibiotics can prolong the survival time of scrapie-infected animalsJ Virol19977112968596899371634
   PubMed Web of Science ®Google Scholar
• MasulloCMacchiGXiYGPocchiariMFailure to ameliorate Creutzfeldt-Jakob disease with amphotericin B therapyJ Infect Dis199216547847851552216
   PubMed Web of Science ®Google Scholar
• EnariMFlechsigEWeissmannCScrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibodyProc Natl Acad Sci U S A200198169295929911470893
   PubMed Web of Science ®Google Scholar
• PeretzDWilliamsonRAKanekoKAntibodies inhibit prion propagation and clear cell cultures of prion infectivityNature2001412684873974311507642
   PubMed Web of Science ®Google Scholar
• HeppnerFLMusahlCArrighiIPrevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodiesScience2001294554017818211546838
   PubMed Web of Science ®Google Scholar
• WhiteAREneverPTayebiMMonoclonal antibodies inhibit prion replication and delay the development of prion diseaseNature20034226927808312621436
   PubMed Web of Science ®Google Scholar
• SchenkDBarbourRDunnWImmunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature1999400674017317710408445
   PubMed Web of Science ®Google Scholar
• MasliahERockensteinEAdameAEffects of alpha-synuclein immunization in a mouse model of Parkinson’s diseaseNeuron200546685786815953415
   PubMed Web of Science ®Google Scholar
• MadampageCAMäättänenPMarciniukKBinding of bovine T194A PrPC by PrPSc-specific antibodies: potential implications for immunotherapy of familial prion diseasesPrion20137430131123787697
   PubMed Web of Science ®Google Scholar
• Grasbon-FrodlELorenzHMannUNitschRMWindlOKretzschmarHALoss of glycosylation associated with the T183A mutation in human prion diseaseActa Neuropathol2004108647648415558291
   PubMed Web of Science ®Google Scholar
• MäättänenPTaschukRMarciniukKPrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrPc in highly susceptible Tga20 micePrion20137543443924105298
   PubMed Web of Science ®Google Scholar
• FischerMRülickeTRaeberAPrion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapieEMBO J1996156125512648635458
   PubMed Web of Science ®Google Scholar
• RossetMBBalleriniCGregoireSMetharomPCarnaudCAucouturierPBreaking immune tolerance to the prion protein using prion protein peptides plus oligodeoxynucleotide-CpG in miceJ Immunol200417295168517415100253
   PubMed Web of Science ®Google Scholar
• GoniFPrelliFSchreiberFHigh titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated miceNeuroscience2008153367968618407424
   PubMed Web of Science ®Google Scholar
• NiklesDBachPBollerKCircumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrPJ Virol20057974033404215767405
   PubMed Web of Science ®Google Scholar
• CardinaleABioccaSGene-based antibody strategies for prion diseasesInt J Cell Biol2013201371040624027584
   PubMedGoogle Scholar
• PorterDDPorterHGCoxNAFailure to demonstrate a humoral immune response to scrapie infection in miceJ Immunol19731115140714104200779
   PubMed Web of Science ®Google Scholar
• SpinnerDSKascsakRBLaFauciGCpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein [PrP.sup.Sc] in mice immunized with 139A scrapie-associated fibrilsJ Leukoc Biol20078161374138517379700
   PubMed Web of Science ®Google Scholar
• SongCHFuruokaHKimCLEffect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected miceJ Gen Virol20088961533154418474571
   PubMed Web of Science ®Google Scholar
• LuginbuhlBKanyoZJonesRMDirected evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretationJ Mol Biol20063631759716962610
   PubMed Web of Science ®Google Scholar
• Padiolleau-LefevreSAlexandrenneCDkhissiFExpression and detection strategies for an scFv fragment retaining the same high affinity than Fab and whole antibody: implications for therapeutic use in prion diseasesMol Immunol20074481888189617140664
   PubMed Web of Science ®Google Scholar
• ZuberCMittereggerGSchuhmannNDelivery of singlechain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapyJ Gen Virol20088982055206118632978
   PubMed Web of Science ®Google Scholar
• ZinkernagelRMHengartnerHRegulation of the immune response by antigenScience2001293552825125311452115
   PubMed Web of Science ®Google Scholar
• FlegoMAscioneAZamboniSDupuisMLImperialeVCianfrigliaMGeneration of human scFvs antibodies recognizing a prion protein epitope expressed on the surface of human lymphoblastoid cellsBMC Biotechnol200771384517605808
   PubMed Web of Science ®Google Scholar
• MarciniukKMäättänenPTaschukRDevelopment of a multi-valent, PrPSc-specific prion vaccine through rational optimization of three disease-specific epitopesVaccine201432171988199724486363
   PubMed Web of Science ®Google Scholar
• LobelloKRyanJMLiuERipponGBlackRTargeting beta amyloid: a clinical review of immunotherapeutic approaches in Alzheimer’s diseaseInt J Alzheimers Dis2012201262807022292124
   PubMedGoogle Scholar
• Mouillet-RichardSErmonvalMChebassierCSignal transduction through prion proteinScience200028954861925192810988071
   PubMed Web of Science ®Google Scholar
• SolforosiLCriadoJRMcGavernDBCross-linking cellular prion protein triggers neuronal apoptosis in vivoScience200430356631514151614752167
   PubMed Web of Science ®Google Scholar
• KlohnP-CFarmerMLinehanJMPrP antibodies do not trigger mouse hippocampal neuron apoptosisScience201233560645222223800
   PubMed Web of Science ®Google Scholar
• ArsenaultRJLiYPotterAGriebelPJKusalikANapperSInduction of ligand-specific PrP (C) signaling in human neuronal cellsPrion20126547748822918447
   PubMed Web of Science ®Google Scholar
• CauxCDezutter-DambuyantCSchmittDBanchereauJGM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature199236064012582611279441
   PubMed Web of Science ®Google Scholar
• SallustoFLanzavecchiaAEfficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alphaJ Exp Med19941794110911188145033
   PubMed Web of Science ®Google Scholar
• RosenbergSAPackardBSAebersoldPMUse of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary reportN Engl J Med198831925167616803264384
   PubMed Web of Science ®Google Scholar
• FongLHouYRivasAAltered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapyProc Natl Acad Sci U S A200198158809881411427731
   PubMed Web of Science ®Google Scholar
• NestleFOAlijagicSGillietMVaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cellsNat Med1998433283329500607
   PubMed Web of Science ®Google Scholar
• GregoireSLogreCMetharomPIdentification of two immunogenic domains of the prion protein – PrP – which activate class II-restricted T cells and elicit antibody responses against the native moleculeJ Leukoc Biol200476112513415075357
   PubMed Web of Science ®Google Scholar
• BachyVBalleriniCGourdainPMouse vaccination with dendritic cells loaded with prion protein peptides overcomes tolerance and delays scrapieJ Gen Virol201091380982019864503
   PubMed Web of Science ®Google Scholar
• MosmannTRCoffmanRLTH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional propertiesAnnu Rev Immunol198971451732523712
   PubMed Web of Science ®Google Scholar
• StockingerBVeldhoenMMartinBTH17 T cells: linking innate and adaptive immunitySemin Immunol200719635336118023589
   PubMed Web of Science ®Google Scholar
• WingKSakaguchiSRegulatory T cells exert checks and balances on self tolerance and autoimmunityNat Immunol201011171320016504
   PubMed Web of Science ®Google Scholar
• BluestoneJAMackayCRO’SheaJJStockingerBThe functional plasticity of T cell subsetsNat Rev Immunol200991181181619809471
   PubMed Web of Science ®Google Scholar
• GourdainPGregoireSIkenSAdoptive transfer of T lymphocytes sensitized against the prion protein attenuates prion invasion in scrapie-infected miceJ Immunol2009183106619662819846876
   PubMed Web of Science ®Google Scholar
• IkenSBachyVGourdainPTh2 polarised PrP-specific transgenic T-cells confer partial protection against murine scrapiePLoS Pathog201179e100221621909267
   PubMed Web of Science ®Google Scholar
• PrusinerSBWoermanALMordesDAEvidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonismProc Natl Acad Sci U S A201511238E5308E531726324905
   PubMed Web of Science ®Google Scholar
• PolymenidouMClevelandDWPrion-like spread of protein aggregates in neurodegenerationJ Exp Med2012209588989322566400
   PubMed Web of Science ®Google Scholar
• PrusinerSBCell biology. A unifying role for prions in neurodegenerative diseasesScience201233660881511151322723400
   PubMed Web of Science ®Google Scholar
• BakerHFRidleyRMDuchenLWCrowTJBrutonCJInduction of [beta](A4)-amyloid in primates by injection of Alzheimer’s disease brain homogenate – comparison with transmission of spongiform encephalopathyMol Neurobiol19948125398086126
   PubMed Web of Science ®Google Scholar
• KaneMDLipinskiWJCallahanMJEvidence for seeding of [beta]-amyloid by intracerebral infusion of Alzheimer brain extracts in [beta]-amyloid precursor protein-transgenic miceJ Neurosci200020103606361110804202
   PubMed Web of Science ®Google Scholar
• Meyer-LuehmannMCoomaraswamyJBolmontTExogenous induction of cerebral [beta]-amyloidogenesis is governed by agent and hostScience200631357941781178416990547
   PubMed Web of Science ®Google Scholar
• EiseleYSObermullerUHeilbronnerGPeripherally applied Aβ-containing inoculates induce cerebral β-amyloidosisScience2010330600698098220966215
   PubMed Web of Science ®Google Scholar
• ClavagueraFBolmontTCrowtherRATransmission and spreading of tauopathy in transgenic mouse brainNat Cell Biol200911790991319503072
   PubMed Web of Science ®Google Scholar
• EriksenJLDawsonTMDicksonDWPetrucelliLCaught in the act: [alpha]-synuclein is the culprit in Parkinson’s diseaseNeuron200340345345614642269
   PubMed Web of Science ®Google Scholar
• DauerWPrzedborskiSParkinson’s disease: mechanisms and modelsNeuron200339688990912971891
   PubMed Web of Science ®Google Scholar
• LukKCKehmVMCarrollJPathological α-synuclein transmission initiates Parkinson-like neurodegeneration in non-transgenic miceScience2012338610994995323161999
   PubMed Web of Science ®Google Scholar
• ReynoldsADStoneDKHutterJABennerEJMosleyRLGendelmanHERegulatory T cells attenuate TH17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson’s diseaseJ Immunol201018452261227120118279
   PubMed Web of Science ®Google Scholar
• ClevelandDWRothsteinJDFrom Charcot to Lou Gehrig: deciphering selective motor neuron death in ALSNat Rev Neurosci20012280681911715057
   PubMed Web of Science ®Google Scholar
• BruijinLIMillerTMClevelandDWUnravelling the mechanisms involved in motor neuron degeneration in ALSAnnu Rev Neurosci20042772374915217349
   PubMed Web of Science ®Google Scholar
• RosenDRSiddiqueTPattersonDMutations in Cu/Zn super-oxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature1993362641559628446170
   PubMed Web of Science ®Google Scholar
• GradLIGuestWCYanaiAIntermolecular transmission of superoxide dismutase 1 misfolding in living cellsProc Nat Acad Sci U S A2011108391639816403
   PubMed Web of Science ®Google Scholar
• SmethurstPSidleKCLHardyJReview: prion-like mechanisms of transactive response DNA binding protein of 43kDa (TDP-43) in amyotrophic lateral sclerosis (ALS)Neuropathol Appl Neurobiol201541557859725487060
   PubMed Web of Science ®Google Scholar
• RenPHLaucknerJEKachirskaiaIHeuserJEMelkiRKopitoRRCytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregatesNat Cell Biol20092221922519151706
   PubMed Web of Science ®Google Scholar
• FurukawaYKanekoKWatanabeSYamanakaKNukinaNA seeding reaction recapitulates intracellular formation of sarkosyl-insoluble TAR DNA binding protein-43 inclusionsJ Biol Chem201128616186641867221454603
   PubMed Web of Science ®Google Scholar